| 2026-01-27 |
财报披露：
美东时间 2026-01-27 盘前发布财报
|
| 2025-10-28 |
详情>>
股本变动：
变动后总股本90583.86万股
|
| 2025-10-28 |
详情>>
业绩披露：
2025年三季报(累计)每股收益13.27美元,归母净利润120.46亿美元,同比去年增长35.93%
|
| 2025-10-01 |
详情>>
内部人交易：
HOOPER MICHELE J等共交易8笔
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益10.66美元,归母净利润96.98亿美元,同比去年增长245.49%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益6.90美元,归母净利润62.92亿美元,同比去年增长546.56%
|
| 2025-04-21 |
股东大会：
将于2025-06-02召开股东大会
会议内容 ▼▲
- 1.Elect the ten nominees set forth in the attached proxy statement to UnitedHealth Group’s (the Company) Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company’s named executive officers as disclosed in the attached proxy statement (Say-on-Pay) vote.
3.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025.
4.Consider the shareholder proposal set forth in the attached proxy statement, if properly presented at the Annual Meeting.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益15.64美元,归母净利润144.05亿美元,同比去年增长-35.64%
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益21.47美元,归母净利润201.20亿美元,同比去年增长16.40%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益9.61美元,归母净利润88.62亿美元,同比去年增长-47.64%
|
| 2024-08-09 |
详情>>
业绩披露：
2023年中报每股收益11.91美元,归母净利润110.85亿美元,同比去年增长9.79%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益3.05美元,归母净利润28.07亿美元,同比去年增长-74.68%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-1.53美元,归母净利润-14.09亿美元,同比去年增长-125.11%
|
| 2024-04-22 |
股东大会：
将于2024-06-03召开股东大会
会议内容 ▼▲
- 1.Election of Ten Directors
2.Advisory Approval of Executive Compensation
3.Ratification of Independent Registered Public Accounting Firm
4.Shareholder Proposal Requiring a Political Contributions Congruency Report
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益24.12美元,归母净利润223.81亿美元,同比去年增长11.24%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益18.20美元,归母净利润169.26亿美元,同比去年增长10.20%
|
| 2023-04-21 |
股东大会：
将于2023-06-05召开股东大会
会议内容 ▼▲
- 1.Elect the nine nominees set forth in the attached proxy statement to the Company’s Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company’s named executive officers as disclosed in the attached proxy statement (Say-on-Pay) vote.
3.Conduct an advisory vote to approve the frequency of holding future Say-on-Pay votes (Say-on-Frequency).
4.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023.
5.Consider the shareholder proposals set forth in the attached proxy statement, if properly presented at the Annual Meeting.
|
| 2023-04-21 |
股东大会：
将于2023-06-05召开股东大会
会议内容 ▼▲
- 1.Elect the nine nominees set forth in the attached proxy statement to the Company’s Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company’s named executive officers as disclosed in the attached proxy statement (Say-on-Pay) vote.
3.Conduct an advisory vote to approve the frequency of holding future Say-on-Pay votes (Say-on-Frequency).
4.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023.
5.Consider the shareholder proposals set forth in the attached proxy statement, if properly presented at the Annual Meeting.
|
| 2022-04-22 |
股东大会：
将于2022-06-06召开股东大会
会议内容 ▼▲
- 1.Elect the eight nominees set forth in the attached proxy statement to the Company’s Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company’s named executive officers as disclosed in the attached proxy statement (a “Say on Pay”) vote.
3.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2022.
4.Consider the shareholder proposals set forth in the attached proxy statement, if properly presented at the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-26 |
股东大会：
将于2021-06-07召开股东大会
会议内容 ▼▲
- 1.Elect the nine nominees set forth in the attached proxy statement to the Company's Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement (a "Say on Pay") vote.
3.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2021.
4.Approve an amendment to the UnitedHealth Group 1993 Employee Stock Purchase Plan.
5.Consider the shareholder proposal set forth in the attached proxy statement, if properly presented at the Annual Meeting.
|
| 2020-04-17 |
股东大会：
将于2020-06-01召开股东大会
会议内容 ▼▲
- 1.Elect the ten nominees set forth in the attached proxy statement to the Company's Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement (a "Say on Pay") vote.
3.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2020.
4.Approve the UnitedHealth Group 2020 Stock Incentive Plan.
5.Consider a shareholder proposal set forth in the attached proxy statement, if properly presented at the Annual Meeting.
|
| 2020-02-17 |
除权日：
美东时间 2020-03-13 每股派息1.08美元
|
| 2019-11-08 |
除权日：
美东时间 2019-12-06 每股派息1.08美元
|
| 2019-08-13 |
除权日：
美东时间 2019-09-13 每股派息1.08美元
|
| 2019-06-05 |
除权日：
美东时间 2019-06-14 每股派息1.08美元
|
| 2019-04-19 |
股东大会：
将于2019-06-03召开股东大会
会议内容 ▼▲
- 1.Elect the eleven nominees set forth in the attached proxy statement to the Company's Board of Directors.
2.Conduct an advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement (a "Say-on-Pay" vote).
3.Ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2019.
4.Consider a shareholder proposal set forth in the attached proxy statement, if properly presented at the Annual Meeting.
5.Transact other business that properly may come before the Annual Meeting or any adjournments or postponements of the meeting.
|
| 2019-02-27 |
除权日：
美东时间 2019-03-08 每股派息0.90美元
|
| 2018-11-09 |
除权日：
美东时间 2018-11-30 每股派息0.90美元
|
| 2018-08-08 |
除权日：
美东时间 2018-09-06 每股派息0.90美元
|
| 2018-06-05 |
除权日：
美东时间 2018-06-15 每股派息0.90美元
|
| 2018-04-20 |
股东大会：
将于2018-06-04召开股东大会
会议内容 ▼▲
- 1.To elect the eleven nominees set forth in the attached proxy statement to the Company's Board of Directors.
2.An advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement (a "Say-on-Pay" vote).
3.To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2018.
4.To transact other business that properly may come before the Annual Meeting or any adjournments or postponements of the meeting.
|
| 2018-02-13 |
除权日：
美东时间 2018-03-08 每股派息0.75美元
|
| 2017-11-07 |
除权日：
美东时间 2017-11-30 每股派息0.75美元
|
| 2017-08-17 |
除权日：
美东时间 2017-09-07 每股派息0.75美元
|
| 2017-06-07 |
除权日：
美东时间 2017-06-15 每股派息0.75美元
|
| 2017-04-21 |
股东大会：
将于2017-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the nine nominees set forth in the attached proxy statement to the Company's Board of Directors.
2.An advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the attached proxy statement (a "Say-on-Pay" vote).
3.An advisory vote regarding the frequency of holding future Say-on-Pay votes.
4.To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2017.
5.To consider a shareholder proposal set forth in the attached proxy statement, if properly presented at the Annual Meeting.
6.To transact other business that properly may come before the Annual Meeting or any adjournments or postponements of the meeting.
|
| 2017-02-09 |
除权日：
美东时间 2017-03-08 每股派息0.63美元
|
| 2016-11-09 |
除权日：
美东时间 2016-11-30 每股派息0.63美元
|
| 2016-08-03 |
除权日：
美东时间 2016-09-07 每股派息0.63美元
|
| 2016-06-08 |
除权日：
美东时间 2016-06-15 每股派息0.63美元
|
| 2016-04-22 |
股东大会：
将于2016-06-06召开股东大会
会议内容 ▼▲
- 1.To elect the ten nominees that are set forth in the attached proxy statement to the Company's Board of Directors.
2.An advisory vote to approve the compensation paid to the Company's named executive officers as disclosed in the proxy statement.
3.To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2016.
4.To transact other business that properly may come before the Annual Meeting or any adjournments or postponements of the meeting.
|
| 2016-02-10 |
除权日：
美东时间 2016-03-09 每股派息0.50美元
|
| 2015-11-06 |
除权日：
美东时间 2015-12-02 每股派息0.50美元
|
| 2015-08-24 |
复牌提示：
2015-08-24 09:30:54 停牌，复牌日期 2015-08-24 09:36:23
|
| 2015-08-12 |
除权日：
美东时间 2015-09-09 每股派息0.50美元
|
| 2015-06-03 |
除权日：
美东时间 2015-06-11 每股派息0.50美元
|
| 2015-02-11 |
除权日：
美东时间 2015-03-11 每股派息0.38美元
|
| 2014-11-06 |
除权日：
美东时间 2014-12-03 每股派息0.38美元
|
| 2014-08-12 |
除权日：
美东时间 2014-09-10 每股派息0.38美元
|
| 2014-06-04 |
除权日：
美东时间 2014-06-12 每股派息0.38美元
|
| 2014-02-12 |
除权日：
美东时间 2014-03-12 每股派息0.28美元
|
| 2013-11-07 |
除权日：
美东时间 2013-12-04 每股派息0.28美元
|
| 2013-08-13 |
除权日：
美东时间 2013-09-11 每股派息0.28美元
|
| 2013-06-05 |
除权日：
美东时间 2013-06-13 每股派息0.28美元
|
| 2013-02-06 |
除权日：
美东时间 2013-03-13 每股派息0.21美元
|
| 2012-10-29 |
除权日：
美东时间 2012-12-07 每股派息0.21美元
|
| 2012-08-07 |
除权日：
美东时间 2012-09-12 每股派息0.21美元
|
| 2012-06-06 |
除权日：
美东时间 2012-06-13 每股派息0.21美元
|
| 2012-02-08 |
除权日：
美东时间 2012-03-01 每股派息0.16美元
|
| 2011-11-03 |
除权日：
美东时间 2011-12-05 每股派息0.16美元
|
| 2011-08-02 |
除权日：
美东时间 2011-09-02 每股派息0.16美元
|
| 2011-05-25 |
除权日：
美东时间 2011-06-03 每股派息0.16美元
|
| 2011-02-09 |
除权日：
美东时间 2011-03-03 每股派息0.13美元
|
| 2010-11-02 |
除权日：
美东时间 2010-12-03 每股派息0.13美元
|
| 2010-08-03 |
除权日：
美东时间 2010-09-10 每股派息0.13美元
|
| 2010-05-25 |
除权日：
美东时间 2010-06-03 每股派息0.13美元
|